Peter Barton Hutt Joins Atelerix Life Sciences Board of Directors
Distinguished Counsel and FDA Regulatory Scholar Will Lend His Expertise on Corporate and Strategic Matters His extensive experience and knowledge of life sciences, including expertise around opioids in our healthcare system, will be real assets as we pioneer a new approach to the opioid crisis.” — David Kalergis, CEO of Atelerix Life Sciences Inc.CHARLOTTESVILLE, VA, …
Peter Barton Hutt Joins Atelerix Life Sciences Board of Directors Read More »